Down-regulation of PARP1 by miR-891b sensitizes human breast cancer cells to alkylating chemotherapeutic drugs
Archives of Gynecology and Obstetrics Aug 11, 2017
Xu S, et al. – The goal of the study described in this paper was to investigate the impacts of miR–891b on sensitizing breast cancer cells to alkylating chemotherapeutic drugs through Poly [ADP–ribose] polymerase (PARPs). The current study showed that MiR–891b increases the sensitivity of the breast cancer cells (HCC1806) to the cytotoxic impacts of the chemotherapeutic agent Methylnitronitrosoguanidine (MNNG) by suppressing the expression of PARP1.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries